Basics |
Amicus Therapeutics, Inc.
Amicus Therapeutics Inc is a biopharmaceutical company. It is engaged in the discovery, development and commercialization of next-generation medicines.
|
IPO Date: |
May 31, 2007 |
Sector: |
Healthcare |
Industry: |
Biotech |
Market Cap: |
$2.46B |
Activated in VL: |
True |
Average Daily Range |
Avg Daily Range: |
$0.23 | 2.67%
|
Avg Daily Range (30 D): |
$0.13 | 1.94%
|
Avg Daily Range (90 D): |
$0.13 | 2.02%
|
Institutional Daily Volume |
Avg Daily Volume: |
1.51M |
Avg Daily Volume (30 D): |
3.61M |
Avg Daily Volume (90 D): |
3.99M |
Trade Size |
Avg Trade Size (Sh.): |
147 |
Avg Trade Size (Sh.) (30 D): |
158 |
Avg Trade Size (Sh.) (90 D): |
161 |
Institutional Trades |
Total Inst.Trades: |
7,354 |
Avg Inst. Trade: |
$2.9M |
Avg Inst. Trade (30 D): |
$2.63M |
Avg Inst. Trade (90 D): |
$3.1M |
Avg Inst. Trade Volume: |
.26M |
Avg Inst. Trades (Per Day): |
2 |
Market Closing Trades |
Avg Closing Trade: |
$3.58M |
Avg Closing Trade (30 D): |
$4.1M |
Avg Closing Trade (90 D): |
$4.24M |
Avg Closing Volume: |
324.07K |
|
|
Financials |
|
TTM |
Q2 2025 |
Q1 2025 |
Basic EPS
|
|
$-.08
|
$-.07
|
Diluted EPS
|
|
$-.08
|
$-.07
|
Revenue
|
$
|
$ 154.69M
|
$ 125.25M
|
Gross Profit
|
$
|
$ 139.47M
|
$ 113.55M
|
Net Income / Loss
|
$
|
$ -24.42M
|
$ -21.69M
|
Operating Income / Loss
|
$
|
$ -9.47M
|
$ -7.95M
|
Cost of Revenue
|
$
|
$ 15.22M
|
$ 11.7M
|
Net Cash Flow
|
$
|
$ -22.72M
|
$ -31.98M
|
PE Ratio
|
|
|
|
|
|
|